Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States.

"CONFLICT OF INTEREST Dr. Jason A. Efstathiou is an Editorial Board Member of this journal but was not involved in the peer-review process nor had access to any information regarding its peer-review. Dr. Efstathiou reports consulting fees from Blue Earth Diagnostics, Boston Scientific, AstraZeneca, and Genentech. Dr. Efstathiou reports participation on a Data Safety Monitoring Board or Advisory Board at Merck, Roivant Pharma, Myovant Sciences, Janssen, Bayer Healthcare, Progenics Pharmaceuticals, Pfizer, Astellas, Gilead, Lantheus, Blue Earth Diagnostics, and Angiodynamics. Dr. Efstathiou reports board membership at Massachusetts Prostate Cancer Coalition (MPCC), American College of Radiation Oncology (ACRO), and Radiation Oncology Institute (ROI). Isabella R. Pompa, David Qi, Anushka Ghosh, Saveli I. Goldberg, and Dr. Sophia C. Kamran have no conflicts of interest to report."

"FUNDING Dr. Chino is funded in part through the NIH/NCI Support Grant P30 CA008748."